Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06480955 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

BOne Metastases REgistry for Patients Undergoing cryoAbLation With curatIve purpoSe

Study acronym: BOREALIS
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Start date changed from estimate of Nov 2024 to Apr 1, 2025
    • Study sites: 0 to 5
    • Primary completion date: Nov 2027 to Apr 2027
    • Study completion date: Nov 2027 to Apr 2028
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
BOREALIS is a multicentre, prospective, observational cohort study designed to investigate the effectiveness, feasibility, safety and impact on pain and quality of life of curative-intent cryoablation for the treatment of bone metastases in patients with oligometastatic or bone oligo-progressive disease.
Trial Details
NCT Number NCT06480955
Lead Sponsor Cardiovascular and Interventional Radiological Society of Europe
Collaborators: Boston Scientific Corporation
Conditions
(from sponsor)		 Bone Metastases
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov